Salah Mohamed El Sayed1, 2,
,
Hamdi H. Almaramhy3,
Yasmeen Talal Aljehani4,
Ahmed M. Okashah5,
Mariam E. El-Anzi6,
Mansour Barakah AlHarbi7,
Rehab El-Tahlawi8, 9,
Manal Mohamed Helmy Nabo10,
Moutasem Salih Aboonq11,
Osama Hamouda12,
Osama Alhadramy13 1Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
2Department of Medical Biochemistry, Sohag Faculty of Medicine, Sohag University, Egypt;Integrative Medicine and Prophetic Medicine Course and Research, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
3Department of surgery, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
4Family medicine programme & Ministry of Health Affairs & Sayed Al-Shuhada Primary Health Care Center, Al-Madinah Al-Munawwarah, Saudi Arabia
5Academic Affairs Director And Consultant Clinical Immunologist, Al-Madinah Directorate of Health, Al-Madinah Al-Munawwarah, Ministry of Health, Saudi Arabia
6Diabetic Center in King Fahd Hospital & Said Alshohada Primary Health Care Center, Al-Madinah Al-Munawwarah, Saudi Arabia
7Head of training and academic affairs and Designated Institutional Official (DIO), King Fahad Hospital, Al-Madinah and Leader of Training and Academic Affairs Taskforce, Al-Madinah Al-Munawwarah, Saudi Arabia
8Department of Microbiology, College of Medicine, Taibah University, Saudi Arabia
90Department of Microbiology, Faculty of Medicine, Zagazig University, Egypt
101Division of Pediatric Cardiology, Pediatrics Department, Maternity and children hospital, Hail, Saudi Arabia
112Department of Medical Physiology, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
12Integrative Medicine and Prophetic Medicine Course and Research, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
133Division of Cardiology, Department of Medicine, Taibah College of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia
American Journal of Public Health Research.
2020,
Vol. 8 No. 2, 54-60
DOI: 10.12691/ajphr-8-2-3
Copyright © 2020 Science and Education PublishingCite this paper: Salah Mohamed El Sayed, Hamdi H. Almaramhy, Yasmeen Talal Aljehani, Ahmed M. Okashah, Mariam E. El-Anzi, Mansour Barakah AlHarbi, Rehab El-Tahlawi, Manal Mohamed Helmy Nabo, Moutasem Salih Aboonq, Osama Hamouda, Osama Alhadramy. The Evidence-Based TaibUVID Nutritional Treatment for Minimizing COVID-19 Fatalities and Morbidity and eradicating COVID-19 pandemic: A novel Approach for Better Outcomes (A Treatment Protocol).
American Journal of Public Health Research. 2020; 8(2):54-60. doi: 10.12691/ajphr-8-2-3.
Correspondence to: Salah Mohamed El Sayed, Department of Clinical Biochemistry and Molecular Medicine, Taibah Faculty of Medicine, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia. Email:
salahfazara@yahoo.comAbstract
With the continuously expanding terrible pandemic of COVID-19 infection, globally increasing numbers of COVID-19 patients and contacts progressively jump to heavy burdens beyond capabilities. Developing and poor countries may face humanity disasters in the next few days unless urgent measures are rapidly performed. Standard anti-COVID-19 treatment should inhibit COVID-19 replication, repair virus-induced tissue damage and enhance patients' immunity. Unfortunately, such criteria are still lacking in current treatments resulting in relatively high viral infectivity, morbidity and mortality. Based on previous prophetic medicine research experience and the modern literature, we introduce TaibUVID therapy as a novel evidence-based medicinal nutritional treatment for eradicating COVID-19 pandemic. TaibUVID stands for Taibah University anti-COVID-19 treatment as a novel evidence-based approach (using natural products) for treating COVID-19 patients. A single TaibUVID dose includes: 1 small spoonful (tea spoonful) of nigella sativa oil (or 2 gram nigella sativa seeds) mixed with 1 gram of grinded anthemis hyalina mixed with 1 large spoonful of natural honey. This mixture is to be chewed in the mouth and swallowed orally for both COVID-19 contacts and patients. We adjusted dosing regimen and period of treatment into three clinical levels including contacts or prophylaxis, mild cases and severe case (with pneumonia and ventilated patients). We also introduce novel nigella sativa oil (or nigella sativa decoction) nebulization for local treatment of pneumonia or bronchopneumonia that is faced in severe COVID-19 cases. Such nebulization exerts pulmonary tissue protection and antiviral effects particularly for ventilated patients. The wonderful report by Ulasli et al. (Ulasli et al. Mol Biol Rep. 2014; 41: 1703-11) deserves a lot of interest where nigella sativa and Anthemis hyalina (chamomile) were confirmed to inhibit corona virus replication maximally. In addition, nigella sativa enhances immunity, exerts tissue protective effects and effectively treats co-morbidities. Oral honey exerts potent antiviral effects, enhances immunity and exerts tissue protective effects. TaibUVID Plus dose includes regular TaibUVID dose plus nigella sativa decoction nebulization ± (if possible Clove oil nebulization/ anthemis hyalina decoction nebulization). Clove oil nebulization is beneficial for difficult berating in some COVID-19 cases as clove is confirmed to exert potent antiviral effects. Our suggested TaibUVID and TaibUVID Plus are promising evidence-based approach to rescue lives, decrease fatalities and put a rapid end to COVID-19 pandemic. In prophetic medicine, Prophet Muhammad peace be upon him recommended treatment using both nigella sativa and oral honey saying: " In the black cumin (nigella sativa), there is a cure for every disease except death" and said also: "Cure is in three: in shartat mihjam, gulp of honey (oral honey), and cauterization. I do not recommend my nation to cauterize".
Keywords